Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...
tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...
TipRanks on MSN
Circio Holding ASA to Present Latest circVec RNA Platform Results in Upcoming Webcast
The latest update is out from Targovax ASA ( (GB:0RIS) ).
The SRV8 was hastily built from the bones of the final pre-production M12. Engine displacement is still 5.7 liters, but here ...
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...
At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest accelerated protein and antibody services. The ...
Authors, Creators & Presenters: Miaomiao Wang (Shanghai University), Guang Hua (Singapore Institute of Technology), Sheng Li (Fudan University), Guorui Feng (Shanghai University) ----------- PAPER A ...
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...
Learn how advances in stabilization, automation, and SR-DLS are making PEI-based transient transfection more efficient, ...
With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work ...
The dangers posed to Canada’s cultural health and national security by Islamism have been known for decades ...
In vivo platform enables efficient, site-specific CAR gene insertion under control of an endogenous T cell promoter, producing functional CART ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback